Alsporin 125mg/5ml

Suspension

Generics : Cephalexin

Manufacturer : Renata Limited

Best Price * TK 82.24

* Delivery will be done in Dhaka city only.

Alternative Product

Capsule Alexin 250mg Renata Limited

Tk 5.58

Tablet Alsporin 250mg Renata Limited

Tk 6.60

Tablet Alsporin 500mg Renata Limited

Tk 12.19

Capsule Acelex 500mg Acme Laboratories Ltd.

Tk 12.50

Capsule Acelex 250mg Acme Laboratories Ltd.

Tk 6.60

More Information About - Alsporin 125mg/5ml

Description

Generic Name

Cephalexin

Precaution

Hypersensitivity to penicillins; pseudomembranous colitis; renal failure; pregnancy and lactation. Lactation: Drug excreted in breast milk; use with caution

Indication

Pneumonia, Otitis media, Bacterial endocarditis, Streptococcal pharyngitis, Cellulitis, Respiratory tract infections, Urinary tract infections, Bone and Joint Infections, Genitourinary tract infections, Acute prostatitis

Contra Indication

Hypersensitivity to cephalosporins.

Dose

N/A

Side Effect

GI disturbances (e.g. nausea, vomiting, diarrhoea, abdominal discomfort), dyspepsia; allergic reactions (e.g. rash urticaria, angioedema); genital and anal pruritus, genital candidiasis, vaginitis and vaginal discharge, dizziness, fatigue, headache, agitation, confusion, hallucinations, arthralgia, arthritis and joint disorders; eosinophilia, neutropenia, thrombocytopenia, haemolytic anaemia, slightly elevated AST and ALT. Rarely, erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis; cholestatic jaundice, transient hepatitis. Potentially Fatal: Anaphylactic reactions; nephrotoxicity.

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Cefalexin binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Interaction

Concurrent use w/ metfromin may result to fatal lactic acidosis. May enhance the anticoagulant effect of vit K antagonists (e.g. warfarin). Increased risk of nephrotoxicity w/ potent diuretics (e.g. ethacrynic acid, furosemide) and other potentially nephrotoxic antibiotics (e.g. aminoglycosides, polymyxin, colistin). Prothrombin time may be prolonged when used concomitantly w/ oral anticoagulants. May reduce the effects of OCs. Hypokalaemia may result from concomitant use of cefalexin and cytotoxic drugs for leukaemia. Uricosuric drugs (e.g. probenecid) may suppress renal excretion, resulting to increased plasma levels of cefalexin. May diminish the therapeutic effect of Na picosulfate, BCG and typhoid vaccine. May reduce serum level w/ multivitamins/minerals.

Pregnancy Category Note

Pregnancy There are no adequate and well-controlled studies Available data from published epidemiologic studies and pharmacovigilance case reports over several decades with cephalosporin use, use in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes Animal data Animal reproduction studies with mice and rats using oral doses of cephalexin that are 0.6- and 1.2-times the maximum recommended human dose (MRHD) based on body surface area during organogenesis revealed no evidence of harm to the fetus; estimated background risk of major birth defects and miscarriage for indicated population is unknown Lactation Data from a published clinical lactation study reports that cephalexin is present in human milk; relative infant dose (RID) is considered to be <1% of maternal weight adjusted dose; there are no data on effects of cephalexin on breastfed child or on milk production Development of health benefits of breastfeeding should be considered along with mother?s clinical need for therapy and any potential adverse effects on breastfed child from therapy or from underlying maternal condition

Adult Dose

Oral Bone and joint infections; Respiratory tract infections, Genitourinary Tract Infections, Otitis Media Adults 1 to 4 g/day in divided doses. Usual dose is 250 mg every 6 hours. Streptococcal pharyngitis, skin and skin structure infections, uncomplicated cystitis, cellulitis and mastitis >15 years 500 mg every 12 hours.

Child Dose

Children 25 to 50 mg/kg/day q12h For streptococcal pharyngitis in patients >1year old and for skin and skin structure infections, divide total daily dose and give every 12 hours. In sever infections, 75?100 mg/kg/day for bone and joint, otitis media or severe infections q6?8h Beta-hemolytic streptococcal infections: Continue treatment for at least 10 days.

Renal Dose

Renal impairment: CrCl (ml/min) 40-50 Max: 3 g daily. 10-40 Max: 1.5 g daily. <10 Max: 750 mg daily.

Administration

May be taken with or without food. May be taken w/ meals to reduce GI discomfort.

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.